Financial statements Drogomost
Balance sheet data of DROGOMOST
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 4 592 695,40 | 5 119 790,72 | 4 997 006,02 | 4 780 720,39 | 4 446 384,42 | 4 446 442,28 |
| A. Fixed assets | 1 319 294,04 | 1 520 897,93 | 1 503 225,26 | 1 484 804,43 | 1 530 052,17 | 1 409 819,64 |
| B. Current assets | 3 273 401,36 | 3 598 892,79 | 3 493 780,76 | 3 295 915,96 | 2 916 332,25 | 3 036 622,64 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 592 695,40 | 5 119 790,72 | 4 997 036,42 | 4 780 720,39 | 4 446 384,42 | 4 446 442,28 |
| A. Equity | 4 389 294,80 | 4 544 679,79 | 4 495 437,23 | 4 392 206,97 | 4 153 486,87 | 4 160 439,12 |
| B. Liabilities and provisions for liabilities | 203 400,60 | 575 110,93 | 501 599,19 | 388 513,42 | 292 897,55 | 286 003,16 |
| I. Long-term liabilities | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 203 400,60 | 575 110,93 | 501 599,19 | 388 513,42 | 292 897,55 | 286 003,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.